Atlas Trials

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

Clinical trial NCT02770716 · COMPLETED

Trial details

NCT number
NCT02770716
Sponsor
Mallinckrodt
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatorenal Syndrome
Start date
2016-07-13
Primary completion
2019-07-24
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.